Founder & Chief Executive Officer
Abdullah Baaj, MD, PharmD, is Founder and Chief Executive Officer of Boston Oncology. A physician, pharmacist, and pharmaceutical executive, he founded the company around a defining conviction: a person’s ability to survive or thrive should not be determined by wealth, status, or geography.
Dr. Baaj has set an equally defining ambition for Boston Oncology—to create medicines that touch the lives of one billion patients by 2030. Under his leadership, the company has built an integrated pharmaceutical platform connecting medicine selection, regulatory strategy, advanced manufacturing, supply, market access, and commercial execution. This model brings global innovation into local operating systems designed to expand access and sustain patient use.
His experience spans medical affairs, commercial strategy, GMP manufacturing, pharmaceutical supply, and business development across the Americas and MENA. Before founding Boston Oncology, he held leadership roles at EMD Serono and Biopharm for Scientific Research & Pharmaceutical Manufacturing.
Dr. Baaj earned his MD from Tufts University School of Medicine and his PharmD from Northeastern University. He has also served on the adjunct faculty at Tufts. His leadership reflects a belief that pharmaceutical localization should create value beyond the medicine itself—strengthening community health, transferring knowledge, developing specialized talent, and contributing to sustainable economic growth.